Literature DB >> 4991927

Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis.

H L David.   

Abstract

The fluctuation test shows that Mycobacterium tuberculosis mutates to resistance to isoniazid, streptomycin, ethambutol and rifampin spontaneously and at random. The average mutation rates for the drugs, in the same order, were calculated to be 2.56 x 10(-8), 2.95 x 10(-8), 10(-7), and 2.25 x 10(-10) mutation per bacterium per generation. The relatively high mutation rate to ethambutol resistance and the low mutation rate to rifampin resistance were confirmed by analyzing the increase in the proportion of mutants with time in a growing population of the tubercle bacilli. The highest proportions of mutants to be expected in unselected populations of the tubercle bacilli were calculated from the results of fluctuation tests.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4991927      PMCID: PMC377053          DOI: 10.1128/am.20.5.810-814.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  14 in total

1.  [Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation].

Authors:  G CANETTI; N RIST; J GROSSET
Journal:  Rev Tuberc Pneumol (Paris)       Date:  1963 Feb-Mar

2.  Techniques of drug-resistance tests.

Authors:  G MIDDLEBROOK
Journal:  Am Rev Tuberc       Date:  1954-11

3.  Isolation of Pre-Adaptive Mutants in Bacteria by Sib Selection.

Authors:  L L Cavalli-Sforza; J Lederberg
Journal:  Genetics       Date:  1956-05       Impact factor: 4.562

4.  Bacterial resistance studies with derivatives of isonicotinic acid.

Authors:  W SZYBALSKI; V BRYSON
Journal:  Am Rev Tuberc       Date:  1952-06

5.  Genetic studies on the development of resistance to neomycin and dihydrostreptomycin in Myobacterium ranae.

Authors:  J Y HSIE; V BRYSON
Journal:  Am Rev Tuberc       Date:  1950-09

6.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

Authors:  G Canetti; W Fox; A Khomenko; H T Mahler; N K Menon; D A Mitchison; N Rist; N A Smelev
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

7.  Improvement of drg-sensitivity tests on tubercle bacilli.

Authors:  J L Leat; J Marks
Journal:  Tubercle       Date:  1970-03

8.  Response to treatment with isoniazid plus PAS of tuberculous patients with primary isoniazid resistance.

Authors:  S P Tripathy; N K Menon; D A Mitchison; A S Narayana; P A Somasundaram; H Stott; S Velu
Journal:  Tubercle       Date:  1969-09

9.  Statistical aspects of the proportion method for determining the drug-resistance of tubercle bacilli.

Authors:  J Gálvez-Brandon; K Bartmann
Journal:  Scand J Respir Dis       Date:  1969

10.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

View more
  94 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 2.  Current medical treatment for tuberculosis.

Authors:  Edward D Chan; Michael D Iseman
Journal:  BMJ       Date:  2002-11-30

3.  Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.

Authors:  Gail E Louw; Robin M Warren; Nicolaas C Gey van Pittius; Rosalba Leon; Adelina Jimenez; Rogelio Hernandez-Pando; Christopher R E McEvoy; Melanie Grobbelaar; Megan Murray; Paul D van Helden; Thomas C Victor
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

4.  Treatment of chronic infections with rifamycins: is resistance likely to follow?

Authors:  Richard E Chaisson
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

5.  Biological variability and the emergence of multidrug-resistant tuberculosis.

Authors:  Tawanda Gumbo
Journal:  Nat Genet       Date:  2013-07       Impact factor: 38.330

6.  Species-Specific Interactions of Arr with RplK Mediate Stringent Response in Bacteria.

Authors:  Priyanka Agrawal; Rajagopal Varada; Shivjee Sah; Souvik Bhattacharyya; Umesh Varshney
Journal:  J Bacteriol       Date:  2018-02-23       Impact factor: 3.490

7.  Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.

Authors:  José Francisco García-Rodríguez; N Valcarce-Pardeiro; H Álvarez-Díaz; A Mariño-Callejo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-03       Impact factor: 3.267

Review 8.  Epidemiology and treatment of multidrug resistant tuberculosis.

Authors:  Carole D Mitnick; Sasha C Appleton; Sonya S Shin
Journal:  Semin Respir Crit Care Med       Date:  2008-09-22       Impact factor: 3.119

9.  Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry.

Authors:  M A Norden; T A Kurzynski; S E Bownds; S M Callister; R F Schell
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

10.  Susceptibility of mycobacteria to rifampin.

Authors:  C L Woodley; J O Kilburn; H L David; V A Silcox
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.